Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 35.71 -1.14%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Supernus Pharmaceuticals Interest Expense 2011-2024 | SUPN

Annual Interest Expense Supernus Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
14.6 M -12.9 M -5.05 M 18.2 M 13.8 M 134 K 543 K 1.23 M 4.96 M 7.85 M 3.58 M 1.87 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
18.2 M -12.9 M 4.08 M

Quarterly Interest Expense Supernus Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
4.1 M 3.73 M - - 1.75 M 1.37 M 1.5 M - 1.72 M 1.81 M 1.94 M - 5.92 M 5.47 M 6.1 M - 6.09 M 5.82 M 5.76 M - 5.66 M 5.39 M -1.19 M - 4.37 M 4.32 M 717 K - 148 K 58 K 90 K - 202 K 196 K 179 K - 292 K 331 K 381 K - 1.29 M 1.28 M 1.21 M - 2.87 M 2.14 M 727 K - 880 K 929 K 962 K - 499 K 499 K 360 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
6.1 M -1.19 M 2.14 M